Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Royalty Pharma plc - SIC # 6794 - PATENT OWNERS AND LESSORS
Ticker
Exchange
SIC #
Website
Latest Ticker
RPRX
Nasdaq
6794
https://www.royaltypharma.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Royalty Pharma plc
Royalty Pharma to Present at Upcoming Investor Conferences
- May 13th, 2024 12:15 pm
Here's What Analysts Are Forecasting For Royalty Pharma plc (NASDAQ:RPRX) After Its First-Quarter Results
- May 12th, 2024 1:16 pm
Only Four Days Left To Cash In On Royalty Pharma's (NASDAQ:RPRX) Dividend
- May 11th, 2024 1:14 pm
Royalty Pharma PLC (RPRX): A Strategic SWOT Insight
- May 10th, 2024 5:07 am
Royalty Pharma Reports First Quarter 2024 Results
- May 9th, 2024 11:00 am
Royalty Pharma to Acquire Royalty Interest in Sanofi’s Frexalimab
- May 9th, 2024 10:45 am
Royalty Pharma's (NASDAQ:RPRX) Dividend Will Be $0.21
- May 4th, 2024 12:49 pm
Royalty Pharma (NASDAQ:RPRX) Will Pay A Dividend Of $0.21
- Apr 20th, 2024 12:29 pm
Royalty Pharma to Announce First Quarter 2024 Financial Results on May 9, 2024
- Apr 19th, 2024 12:15 pm
Royalty Pharma Declares Second Quarter 2024 Dividend
- Apr 17th, 2024 12:15 pm
Royalty Pharma plc's (NASDAQ:RPRX) Stock Has Shown A Decent Performance: Have Financials A Role To Play?
- Mar 30th, 2024 1:00 pm
Royalty Pharma to Present at TD Cowen’s 44th Annual Health Care Conference
- Feb 28th, 2024 9:15 pm
Analysts Have Made A Financial Statement On Royalty Pharma plc's (NASDAQ:RPRX) Yearly Report
- Feb 18th, 2024 12:11 pm
Royalty Pharma Full Year 2023 Earnings: EPS: US$2.54 (vs US$0.098 in FY 2022)
- Feb 17th, 2024 12:09 pm
Royalty Pharma PLC (RPRX) Earnings Report: A Detailed Analysis
- Feb 15th, 2024 12:58 pm
Royalty Pharma Reports Q4 and Full Year 2023 Results
- Feb 15th, 2024 12:30 pm
Royalty Pharma To Announce Fourth Quarter And Full Year 2023 Financial Results On February 15, 2024
- Jan 30th, 2024 9:15 pm
Royalty Pharma (NASDAQ:RPRX) Is Paying Out A Larger Dividend Than Last Year
- Jan 22nd, 2024 10:24 am
Royalty Pharma Announces Dividend Increase
- Jan 19th, 2024 1:15 pm
Royalty Pharma Highlights Accomplishments and Provides Business Update at 42nd Annual J.P. Morgan Healthcare Conference
- Jan 8th, 2024 12:00 pm
Scroll